Moderna's Q4 Earnings Preview: What Analysts Expect

Moderna Gears Up for Its Upcoming Earnings Report

As Moderna, Inc. (NASDAQ: MRNA) prepares for its much-anticipated fourth-quarter financial results, the investment community is abuzz with speculation. While analysts are expecting a turbulent quarter, insights from some of Wall Street's most accurate analysts can help illuminate what might lie ahead.

Quarterly Expectations and Profit Projections

Analysts predict that Moderna will report a quarterly loss of approximately $2.68 per share. This stark contrast to the prior year's earnings of 55 cents exemplifies the challenging environment the company is facing. Revenue projections are equally concerning, with expectations hovering around $942.84 million, a sharp decline from $2.81 billion recorded during the same period last year.

Recent Performance and Trends

Despite these gloomy forecasts, it’s crucial to note that Moderna has consistently exceeded analysts' consensus estimates for the past four quarters. This track record has cultivated a degree of investor optimism, even in the face of setbacks.

Analyst Ratings: A Mixed Bag

Recent actions by prominent analysts reveal mixed sentiments about the stock. For instance, Tim Anderson of B of A Securities maintained an Underperform rating while reducing the price target from $41 to $34. This update came on February 11, further reflecting a cautious view of Moderna's trajectory.

Price Target Adjustments

On January 27, Cory Kaimov from Evercore ISI Group also crunched the numbers and decided to cut his price target from $60 to $50 while holding an In-Line rating. This sentiment aligns with John Eade of Argus Research, who took a more defensive stance by downgrading the stock from a Buy to Hold on December 18 of the previous year.

Key Analyst Insights

Further adding to the cautious narrative, JP Morgan analyst Jessica Fye adjusted her projections, maintaining an Underweight rating and lowering the price target from $59 to $45 back in late November. These insights paint a comprehensive picture of the apprehension surrounding Moderna as it approaches its earnings release.

Current Stock Performance

After a span of fluctuating market conditions, Moderna shares recently closed at $31.92, showcasing a 4.5% gain on Thursday. Such performance, while positive, still poses questions about the stock's stability moving forward.

Looking Forward: What Investors Should Consider

For those thinking about adding MRNA stock to their portfolios, it's vital to consider the mixed reviews from analysts as well as previous earnings performances. Understanding the underlying factors influencing these ratings can provide a clearer picture of the company’s potential future.

Preparing for Q4 Results

As the financial report date approaches, investors and market watchers will be keen on any shifts in strategy or operational updates that might emerge from the company. The upcoming earnings call could also offer insights into how Moderna plans to navigate this transitional phase.

Frequently Asked Questions

What earnings per share is Moderna expected to report for Q4?

Analysts expect Moderna to report a loss of $2.68 per share for the fourth quarter.

How does the projected revenue for this quarter compare to last year?

This quarter is projected to yield approximately $942.84 million in revenue, a drop from $2.81 billion the previous year.

Which analysts have recently changed their ratings for Moderna?

Analysts from B of A Securities, Evercore ISI, Argus Research, and JP Morgan have all adjusted their ratings and price targets for Moderna.

What was Moderna's recent stock performance?

Recently, Moderna shares gained 4.5%, closing at $31.92.

What factors should investors watch for in the upcoming earnings release?

Investors should monitor any operational changes, updates on drug development, and broader market conditions that may impact future performance.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.